Aquestive Therapeutics, INC.

Reporting payments is a legal requirement; large totals often reflect large product portfolios.

$1.3Mgeneral payments (2019-2025)
$1.2Mresearch payments (2019-2025)
2,080clinicians paid

General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.

General payments by year

2019 $456K
2020 $146K
2021 $146K
2022 $109K
2024 $5,489
2025 $420K

General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.

Products most associated with its payments

Specialties it works with most

Neurology (Psychiatry & Neurology) $417K
Neurology With Special Qualifications In Child Neurology $276K
Internal Medicine $225K
Allergy & Immunology $57K
Pediatric Allergy/Immunology $53K
Allergy $42K

Clinicians with the largest reported totals

Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.

ClinicianLocationSpecialtyGeneral payments (2019-2025)
Gary Slatko New York, NY Internal Medicine $217,816.67
Paul Mullin New York, NY Neurology (Psychiatry & Neurology) $141,561.83
Jesus Pina Garza Nashville, TN Neurology With Special Qualifications In Child Neurology $49,599.95
David Golden Baltimore, MD Allergy $35,544.11
Matthew Greenhawt Aurora, CO Pediatric Allergy/Immunology $35,354.00
Atiya Khan Fort Wayne, IN Neurology With Special Qualifications In Child Neurology $28,256.62
Rotem Elgavish Lone Tree, CO Neurology (Psychiatry & Neurology) $27,137.81
Nabil Azar Nashville, TN Clinical Neurophysiology $23,711.11
Sami Aboumatar Austin, TX Neurology (Psychiatry & Neurology) $22,883.11
Jose Ferreira Tampa, FL Neurology With Special Qualifications In Child Neurology $21,351.33

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.